Purchase Order 75N92019P00069
Award Date 2/22/19
Potential Completion Date 4/22/21
Potential Value $51K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Sacramento, CA 95605, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media and other biomedical research supplies, is for the delivery of fetal bovine serum under Purchase Order HHSN272201001085P. The $5,027.40 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the supply of BENCHMARK fetal bovine serum. Gemini Bioproducts has previously received numerous...
- This $6,336 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community. The contract is for the delivery of Benchmark FBS - 500mL, catalog #100106. Gemini Bioproducts has received numerous prior awards from NIH to supply fetal bovine serum for cell...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $57,375.00 firm-fixed-price purchase order was for the delivery of 500 mL of benchmark fetal bovine serum, a critical cell culture component used in biomedical research. This order is part of NIAID's ongoing procurement of specialized cell culture media and reagents to support its diverse scientific initiatives....
- This federal contract award, valued at $77,738.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Gemini Bioproducts LLC. The contract is for the procurement of a benchmark fetal bovine serum (FBS) lot to support research characterizing the infectious properties of SARS-CoV-2 variants and developing effective prophylactic and therapeutic vaccine candidates. This is a sole source award, as the specified FBS lot...
- This firm fixed-price purchase order was awarded to Gemini Bioproducts LLC, a for-profit manufacturer of goods, by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The $102,116.06 contract is for the delivery of fetal bovine serum, and is designated as a Total Small Business set-aside. Gemini Bioproducts is a leading supplier of cell culture media, sera, and other reagents to the scientific community, including...
- This federal contract award to Gemini Bioproducts LLC, a leading manufacturer of cell culture media and reagents, provides the National Cancer Institute with Bench Mark FBS-500ML heat-inactivated fetal bovine serum. The $16,135.00 firm fixed price contract is a BPA call, with no set-aside designation. Gemini Bioproducts has previously received numerous awards from the National Institutes of Health and the U.S. Department of Agriculture to supply fetal bovine serum and other critical research...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $6,165.00 firm fixed-price purchase order is for the delivery of 500 ml bottles of fetal bovine serum, a critical cell culture reagent used in biomedical research and pharmaceutical development. The contract has no set-aside designation. Gemini Bioproducts is a leading manufacturer and supplier of cell culture...
- Gemini Bioproducts LLC has been awarded a $19,254.92 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide Fetal Bovine Serum (FBS), U.S. origin, as described in NIH requisition number 2180219. Performance will occur in West Sacramento, California over a period of two months concluding in late September 2023. The contract action was funded through the Department of Health and Human Services and supports the NIH's...
- The U.S. National Heart Lung and Blood Institute awarded a Firm Fixed Price contract to Gemini Bioproducts LLC, a manufacturer of cell culture products, media, sera, and related scientific reagents based in West Sacramento, California. The $11,900 contract is a BPA Call and does not have a set-aside designation. Gemini Bioproducts is a key supplier to federal research institutions, particularly within the biomedical research ecosystem, and has established indefinite delivery/indefinite...
- This is a federal contract award to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents, by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract has a total ceiling value of $26,000.00 and is for the supply of biomaterial products. The contract type is a firm fixed-price purchase order, with an ultimate completion date of October 21, 2015. This award is not associated...
Gemini Bioproducts LLC was awarded a firm fixed price purchase order totaling $51,066.81 by the National Institutes of Health National Heart Lung and Blood Institute to supply 500ml of Benchmark fetal bovine serum. The award was made non-competitively on February 22, 2019 to fulfill a special notice issued on January 31, 2019 for the specified product. Performance will take place in West Sacramento, California by April 22, 2021. No set-aside designation was applied. Gemini Bioproducts additionally holds an indefinite delivery contract from the Federal Emergency Management Agency with a potential value of $200 million to provide testing supplies such as swabs and media in support of the federal COVID-19 response effort.
Generated 2/22/24, 9:28 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notification of Intent to Sole Sourc | 75N92019Q0031 | Department of Health and Human Services National Institutes of Health | Special Notice 1/1 | 1/31/19, 2:59 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($578) | 2/13/24 | |
| Not listed | Not listed | $51.6k | 2/22/19 |